×
S&P 500   3,825.33
DOW   31,097.26
QQQ   282.13
S&P 500   3,825.33
DOW   31,097.26
QQQ   282.13
S&P 500   3,825.33
DOW   31,097.26
QQQ   282.13
S&P 500   3,825.33
DOW   31,097.26
QQQ   282.13
NYSE:TFX

Teleflex Stock Forecast, Price & News

$255.09
+9.24 (+3.76%)
(As of 07/1/2022 12:00 AM ET)
Add
Compare
Today's Range
$245.80
$256.26
50-Day Range
$244.93
$326.35
52-Week Range
$244.81
$428.36
Volume
364,674 shs
Average Volume
351,363 shs
Market Capitalization
$11.96 billion
P/E Ratio
24.79
Dividend Yield
0.55%
Price Target
$384.92

Teleflex Stock Forecast (MarketRank)

Analyst Rating
Moderate Buy
2.58 Rating Score
Upside/​Downside
50.9% Upside
$384.92 Price Target
Short Interest
Healthy
2.45% of Shares Sold Short
Dividend Strength
Weak
Based on Four Factors
Sustainability
-1.53
Upright™ Environmental Score
News Sentiment
0.42mentions of Teleflex in the last 14 days
Based on 2 Articles This Week
Insider Trading
Selling Shares
$853.90 K Sold Last Quarter
Proj. Earnings Growth
9.95%
From $13.97 to $15.36 Per Share

Overall MarketRank

MarketRank is calculated as 30% analysis score, 20% valuation score, 10% short interest score, 10% dividend score, 10% sustainability score, 10% news and social score, and 10% insider trading score.

2.49 out of 5 stars

Medical Sector

47th out of 1,429 stocks

Surgical & Medical Instruments Industry

6th out of 138 stocks

30 days | 90 days | 365 days | Advanced Chart

Receive TFX Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Teleflex and its competitors with MarketBeat's FREE daily newsletter.

Teleflex logo

About Teleflex (NYSE:TFX)

Teleflex Incorporated designs, develops, manufactures, and supplies single-use medical devices for common diagnostic and therapeutic procedures in critical care and surgical applications worldwide. It provides vascular access products that comprise Arrow branded catheters, catheter navigation and tip positioning systems, and intraosseous access systems for the administration of intravenous therapies, the measurement of blood pressure, and the withdrawal of blood samples through a single puncture site. The company also offers interventional products, which consists of various coronary catheters, structural heart therapies, and peripheral intervention and cardiac assist products that are used by interventional cardiologists and radiologists, and vascular surgeons; and Arrow branded catheters, Guideline and Trapliner catheters, the Manta Vascular Closure, and Arrow Oncontrol devices. It provides anesthesia products, such as airway and pain management products to support hospital, emergency medicine, and military channels; and surgical products, including metal and polymer ligation clips, and fascial closure surgical systems that are used in laparoscopic surgical procedures, percutaneous surgical systems, and other surgical instruments. The company also offers interventional urology products comprising the UroLift System, an invasive technology for treating lower urinary tract symptoms due to benign prostatic hyperplasia; and respiratory products, including oxygen and aerosol therapies, spirometry, and ventilation management products for use in various care settings. It provides urology products, such as catheters, urine collectors, and catheterization accessories and products for operative endourology; and bladder management services. The company serves hospitals and healthcare providers, medical device manufacturers, and home care markets. The company was incorporated in 1943 and is headquartered in Wayne, Pennsylvania.

TFX Stock News Headlines

Here's Why Teleflex (TFX) is a Strong Value Stock
Teleflex (NYSE:TFX) Hits New 12-Month Low at $255.86
See More Headlines

Industry, Sector and Symbol

Industry
Surgical & medical instruments
Sub-Industry
Health Care Equipment
Sector
Medical
CUSIP
87936910
Employees
14,000
Year Founded
1943

Company Calendar

Last Earnings
4/28/2022
Ex-Dividend for 6/15 Dividend
5/13/2022
Dividend Payable
6/15/2022
Today
7/02/2022
Next Earnings (Estimated)
8/04/2022
Fiscal Year End
12/31/2022

Price Target and Rating

Average Stock Price Forecast
$384.92
High Stock Price Forecast
$485.00
Low Stock Price Forecast
$315.00
Forecasted Upside/Downside
+50.9%
Consensus Rating
Moderate Buy
Rating Score (0-4)
2.58333333333333
Research Coverage
12 Analysts

Profitability

Net Income
$485.37 million
Pretax Margin
20.07%

Debt

Sales & Book Value

Annual Sales
$2.81 billion
Cash Flow
$18.44 per share
Book Value
$80.15 per share

Miscellaneous

Free Float
46,300,000
Market Cap
$11.96 billion
Optionable
Optionable
Beta
1.13

Social Links















Teleflex Frequently Asked Questions

Should I buy or sell Teleflex stock right now?

12 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for Teleflex in the last year. There are currently 5 hold ratings and 7 buy ratings for the stock. The consensus among Wall Street research analysts is that investors should "moderate buy" Teleflex stock.
View analyst ratings for Teleflex
or view top-rated stocks.

What is Teleflex's stock price forecast for 2022?

12 Wall Street analysts have issued twelve-month price targets for Teleflex's stock. Their TFX stock forecasts range from $315.00 to $485.00. On average, they expect Teleflex's share price to reach $384.92 in the next twelve months. This suggests a possible upside of 50.9% from the stock's current price.
View analysts' price targets for Teleflex
or view top-rated stocks among Wall Street analysts.

How has Teleflex's stock performed in 2022?

Teleflex's stock was trading at $328.48 at the beginning of the year. Since then, TFX shares have decreased by 22.3% and is now trading at $255.09.
View the best growth stocks for 2022 here
.

Are investors shorting Teleflex?

Teleflex saw a increase in short interest during the month of May. As of May 31st, there was short interest totaling 1,200,000 shares, an increase of 41.0% from the May 15th total of 851,100 shares. Based on an average trading volume of 349,200 shares, the short-interest ratio is presently 3.4 days.
View Teleflex's Short Interest
.

When is Teleflex's next earnings date?

Teleflex is scheduled to release its next quarterly earnings announcement on Thursday, August 4th 2022.
View our earnings forecast for Teleflex
.

How were Teleflex's earnings last quarter?

Teleflex Incorporated (NYSE:TFX) issued its quarterly earnings data on Thursday, April, 28th. The medical technology company reported $2.88 earnings per share (EPS) for the quarter, beating the consensus estimate of $2.73 by $0.15. The medical technology company earned $641.70 million during the quarter, compared to the consensus estimate of $631.89 million. Teleflex had a trailing twelve-month return on equity of 17.24% and a net margin of 17.31%. The business's quarterly revenue was up 1.2% compared to the same quarter last year. During the same period in the prior year, the company earned $2.87 EPS.
View Teleflex's earnings history
.

How often does Teleflex pay dividends? What is the dividend yield for Teleflex?

Teleflex announced a quarterly dividend on Monday, May 2nd. Investors of record on Monday, May 16th will be given a dividend of $0.34 per share on Wednesday, June 15th. This represents a $1.36 annualized dividend and a yield of 0.53%. The ex-dividend date is Friday, May 13th.
View Teleflex's dividend history
.

Is Teleflex a good dividend stock?

Teleflex(NYSE:TFX) pays an annual dividend of $1.36 per share and currently has a dividend yield of 0.55%. The dividend payout ratio of Teleflex is 13.22%. This payout ratio is at a healthy, sustainable level, below 75%. Based on earnings estimates, Teleflex will have a dividend payout ratio of 8.85% next year. This indicates that Teleflex will be able to sustain or increase its dividend.
View Teleflex's dividend history.

What guidance has Teleflex issued on next quarter's earnings?

Teleflex updated its FY 2022 earnings guidance on Friday, June, 17th. The company provided earnings per share (EPS) guidance of $13.70-$14.30 for the period, compared to the consensus estimate of $13.97. The company issued revenue guidance of $2.87 billion-$2.92 billion, compared to the consensus revenue estimate of $2.90 billion.

Who are Teleflex's key executives?

Teleflex's management team includes the following people:
  • Mr. Liam J. Kelly, Chairman, Pres & CEO (Age 55, Pay $3.01M) (LinkedIn Profile)
  • Mr. Thomas E. Powell, Exec. VP & CFO (Age 60, Pay $1.44M)
  • Mr. Cameron P. Hicks, Corp. VP & Chief HR Officer (Age 57, Pay $771.45k) (LinkedIn Profile)
  • Mr. Jay White, Corp. VP & Pres of Global Commercial (Age 48, Pay $1.23M)
  • Mr. James P. Winters, Corp. VP, Manufacturing and Supply Chain
  • Mr. John R. Deren, Corp. VP & Chief Accounting Officer
  • Mr. Timothy F. Duffy, VP & Chief Information Officer
  • Mr. John Hsu C.F.A., VP of Investor Relations
  • Mr. Daniel V. Logue, Corp. VP, Gen. Counsel & Sec. (Age 48)
  • Mr. Howard Cyr, Corp. VP & Chief Compliance Officer

What is Liam Kelly's approval rating as Teleflex's CEO?

73 employees have rated Teleflex CEO Liam Kelly on Glassdoor.com. Liam Kelly has an approval rating of 86% among Teleflex's employees.

What other stocks do shareholders of Teleflex own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Teleflex investors own include NVIDIA (NVDA), AbbVie (ABBV), Johnson & Johnson (JNJ), Alibaba Group (BABA), Lam Research (LRCX), ServiceNow (NOW), QUALCOMM (QCOM), Advanced Micro Devices (AMD), Salesforce (CRM) and Cisco Systems (CSCO).

What is Teleflex's stock symbol?

Teleflex trades on the New York Stock Exchange (NYSE) under the ticker symbol "TFX."

How do I buy shares of Teleflex?

Shares of TFX can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is Teleflex's stock price today?

One share of TFX stock can currently be purchased for approximately $255.09.

How much money does Teleflex make?

Teleflex (NYSE:TFX) has a market capitalization of $11.96 billion and generates $2.81 billion in revenue each year. The medical technology company earns $485.37 million in net income (profit) each year or $10.289990 on an earnings per share basis.

How many employees does Teleflex have?

Teleflex employs 14,000 workers across the globe.

When was Teleflex founded?

Teleflex was founded in 1943.

How can I contact Teleflex?

Teleflex's mailing address is 550 E SWEDESFORD RD, WAYNE PA, 19087. The official website for Teleflex is www.teleflex.com. The medical technology company can be reached via phone at (610) 225-6800, via email at [email protected]broadridge.com, or via fax at 215-553-5402.

This page (NYSE:TFX) was last updated on 7/2/2022 by MarketBeat.com Staff

MarketBeat Resources

Premium Research Tools

MarketBeat All Access subscribers can access stock screeners, the Idea Engine, data export tools, research reports, and other premium tools.

Discover All Access

Market Data and Calendars

Looking for new stock ideas? Want to see which stocks are moving? View our full suite of financial calendars and market data tables, all for free.

View Market Data

Investing Education and Resources

Receive a free world-class investing education from MarketBeat. Learn about financial terms, types of investments, trading strategies and more.

Financial Terms
Details Here
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau MarketBeat is rated as Great on TrustPilot

© American Consumer News, LLC dba MarketBeat® 2010-2022. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information | RSS Feeds

© 2022 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer.